Huateng Pharma, a global supplier of pharmaceutical intermediates & chemical products & biological reagent & PEG derivatives, offers CAS NO.119736-16-2 for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.
Application: BPCA (CAS NO.119736-16-2) is an intermeiate of Baloxavir Marboxil.
Find More Baloxavir Marboxil Intermediates>>>
I want to comment